Aziz Zaanan, MD, PhD, is a GI oncologist at the European Georges Pompidou Hospital and full Professor in Gastroenterology at the University of Paris Cité, France.
After training as a medical student at the University of Marseille, France, Professor Zaanan completed his residency (Internat) in Paris and attained his medical degree in 2008. In 2013, he completed a post-doctoral research fellow at Mayo Clinic Rochester for one year. He was working on molecular subtyping of colorectal cancer and its implication for prognosis and treatment. Dr Zaanan is Associate Editor of the journals Cancers, Frontiers in Oncology and Clinics and Research in Hepatology and Gastroenterology. Furthermore, he has authored numerous abstracts at international congresses and has published more than 100 peer-reviewed articles.
Dr Zaanan is a member of the European Society for Medical Oncology (ESMO), and French gastrointestinal cooperative groups and societies, including the PRODIGE intergroup, the Fédération Francophone de Cancérologie Digestive (FFCD) and the Société Nationale Française de Gastro-Entérologie (SNFGE). He was the chairman the AGEO French research group on GI tumours.
Dr Zaanan’s scientific focus is on clinical and translational research in gastrointestinal tract cancers, and in particular in upper GI cancers and MSI tumors.
Amgen, Merck, Roche, Sanofi, Servier, Baxter, Havas Life, Alira Health, Zymeworks, MSD, BMS, AstraZeneca, Daiichi Sankyo